NPS Pharmaceuticals to Present at Needham Healthcare Conference
01 April 2014 - 7:10AM
Business Wire
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) will present at the 13th
Annual Needham Healthcare Conference in New York on Tuesday, April
8, 2014 at 8:00 a.m. ET. The presentation will be available as a
live webcast with a replay available approximately three hours
after the presentation has concluded. Interested parties may access
the webcast from the investors’ calendar of events page on the NPS
website at http://www.npsp.com/calendar.
About NPS Pharmaceuticals
NPS Pharmaceuticals is a global biopharmaceutical company
pioneering and delivering therapies that transform the lives of
patients with rare diseases. The company’s lead product, Gattex®
(teduglutide [rDNA origin]) for injection is approved in the US for
adult patients with Short Bowel Syndrome (SBS) who are dependent on
parenteral support. In the EU, teduglutide (trade name: Revestive®)
is approved for the treatment of adult patients with SBS; patients
should be stable following a period of intestinal adaptation after
surgery. Teduglutide is not approved for the treatment of pediatric
SBS patients. The safety and efficacy of teduglutide in this
population is currently being evaluated in a global registration
trial. A Biologics License Application is undergoing FDA review for
Natpara® (rhPTH [1-84]) for the treatment of hypoparathyroidism, a
rare endocrine disorder characterized by insufficient levels of
parathyroid hormone. The Prescription Drug User Fee Act goal date
for the Natpara application is October 24, 2014. NPS’ earlier stage
pipeline includes NPSP795, a calcilytic compound with potential
application in rare disorders involving increased calcium sensing
receptor activity, such as autosomal dominant hypocalcemia (ADH).
NPS complements its proprietary programs with a royalty-based
portfolio of products and product candidates that includes
agreements with Amgen, GlaxoSmithKline, Janssen Pharmaceuticals,
and Kyowa Hakko Kirin.
NPS Pharmaceuticals, Inc.Gail Brophy,
908-450-5335
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nps (NASDAQ:NPSP)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about (MM) (NASDAQ): 0 recent articles
More Nps Pharmaceuticals, Inc. (MM) News Articles